Quidel Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
9,357.00
204,022.00
191,534.00
169,508.00
36,086.00
43,695
Total Accounts Receivable
29,928.00
34,466.00
18,398.00
24,990.00
67,046.00
76,887
Inventories
27,639.00
24,763.00
26,388.00
26,045.00
67,078.00
67,379
Other Current Assets
11,695.00
11,570.00
4,044.00
4,851.00
161,019.00
5,436
Total Current Assets
78,619.00
274,821.00
240,364.00
225,394.00
331,229.00
193,397
Net Property, Plant & Equipment
48,057.00
49,226.00
52,547.00
50,858.00
61,585.00
73,901
Intangible Assets
143,025.00
122,638.00
112,563.00
111,473.00
540,855.00
512,050
Other Assets
1,784.00
4,865.00
1,031.00
525.00
1,582.00
4,831
Total Assets
271,485.00
451,550.00
406,505.00
409,472.00
948,652.00
816,182
ST Debt & Current Portion LT Debt
441.00
509.00
585.00
98.00
20,184.00
Accounts Payable
6,950.00
12,421.00
8,675.00
16,047.00
27,279.00
Income Tax Payable
20.00
-
-
-
-
Other Current Liabilities
16,598.00
23,455.00
21,570.00
17,467.00
80,885.00
Total Current Liabilities
24,009.00
36,385.00
30,830.00
33,612.00
128,348.00
Long-Term Debt
5,126.00
146,714.00
147,329.00
148,319.00
377,262.00
Provision for Risks & Charges
-
-
-
2,349.00
18,008.00
Deferred Taxes
6,318.00
14,890.00
1,970.00
58.00
430.00
Other Liabilities
12,253.00
8,550.00
7,700.00
3,282.00
184,099.00
Total Liabilities
47,706.00
206,539.00
187,829.00
208,842.00
721,548.00
Common Equity (Total)
223,779.00
245,011.00
218,676.00
200,630.00
227,104.00
Total Shareholders' Equity
223,779.00
245,011.00
218,676.00
200,630.00
227,104.00
Total Equity
223,779.00
245,011.00
218,676.00
200,630.00
227,104.00
Liabilities & Shareholders' Equity
271,485.00
451,550.00
406,505.00
409,472.00
948,652.00

About Quidel

View Profile
Address
12544 High Bluff Drive
San Diego California 92130
United States
Employees -
Website http://www.quidel.com
Updated 07/08/2019
Quidel Corp. engages in the development, manufacture, and market of rapid diagnostic testing solutions. Its portfolio includes immunoassays, molecular diagnostics, virology, and specialty products. Immunoassay tests are for physician offices, hospital laboratories, emergency departments, pharmacies, and other urgent care or alternative site settings.